ARD Sales Q1

anonymous

Guest
Rumor is that rheum and neph sales not going to make goal. Any word on the other ARD disease states? Could be a painful quarter. Worse is that the Acthar franchise appears to be unraveling at an accelerating rate. Less in and less out.
 












Rumor is that rheum and neph sales not going to make goal. Any word on the other ARD disease states? Could be a painful quarter. Worse is that the Acthar franchise appears to be unraveling at an accelerating rate. Less in and less out.
No surprise. We all make one call a day, look for other jobs and shop.